37 results
8-K
EX-10.1
VYNT
Vyant Bio, Inc.
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
restrictive covenants that may apply to the Participant, or other conduct by the Participant that is detrimental to the business or reputation
424B3
9c1vnv
12 Feb 21
Prospectus supplement
9:43pm
S-4/A
l1airtspelru
8 Feb 21
Registration of securities issued in business combination transactions (amended)
10:46am
424B5
mx2i1fi9l3gdl
29 Oct 20
Prospectus supplement for primary offering
5:24pm
424B5
tkn gpwtcgfn5qbddtw
28 Oct 20
Prospectus supplement for primary offering
5:25pm
S-4
po4 3xj0i6ek0c
16 Oct 20
Registration of securities issued in business combination transactions
11:38am
8-K
EX-4.1
v2ux7w4wi o5jqw
18 Jul 18
Cancer Genetics Closes $2.625 million Convertible Note Financing
4:18pm